Y-mAbs Therapeutics, Inc. (YMAB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 347.1M |
| Enterprise Value | 280.68M |
| P/E Ratio | -25.21 |
| PEG Ratio | -192.67 |
| Price/Sales Ratio | 5.85 |
| Price/Book Ratio | 4.46 |
| Enterprise/Revenue | 4.96 |
| Enterprise/EBITDA | -23.5 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | -0.23 |
| Operating Margin | -0.27 |
AD
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.17 |
Income Statement
| Revenue | 87.69M |
| Revenue/Share | 1.48 |
| Gross Profit | 72.43M |
| EBITDA | -30.67M |
| Net Income | -29.67M |
| Diluted EPS | -0.67 |
Balance Sheet
| Total Cash | 62.29M |
| Total Cash/Share | 1.37 |
| Total Debt | 3.12M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4 |
| Book Value Per Share | 1.93 |
Price History
| 52-Week Change | -41.47 |
| 52-Week High | 16.11 |
| 52-Week Low | 3.55 |
| Moving Average 50 Days | 6.84 |
| Moving Average 200 Days | 6.12 |
Statistics
| Average Volume | 905,066 |
| Shares Outstanding | 45.44M |
| % Held by Institutions | 61.58 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
